ArticleAnalytical cellular pathology (Amsterdam)2025

DDX21 Is a Potential Biomarker for Predicting Recurrence and Prognosis in Hepatocellular Carcinoma.

Chengjie Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.